From: miR-486-5p predicted adverse outcomes of SCAP and regulated K. pneumonia infection via FOXO1
 | Healthy individuals | MCAP patients | SCAP patients | P-value |
---|---|---|---|---|
Age | 63.44 ± 10.91 | 63.53 ± 8.51 | 64.60 ± 11.89 | 0.764 |
Gender | 35/17 | 41/27 | 52/31 | 0.729 |
BMI | 24.51 ± 2.37 | 23.54 ± 2.92 | 23.67 ± 2.64 | 0.110 |
Smoking | 29/23 | 37/31 | 43/40 | 0.894 |
Basic disease | Â | Â | Â | 0.957 |
Hypertension | - | 30, 44.12% | 36, 43.37% | Â |
Diabetes | - | 28, 41.18% | 39, 46.99% | Â |
Coronary heart disease | - | 11, 16.18% | 15, 18.07% | Â |
Others | - | 5, 7.35% | 8, 9.64% | Â |
LAC | - | 1.72 ± 0.29 | 3.38 ± 0.79 | < 0.001 |
PCT | - | 1.20 ± 0.27 | 2.34 ± 0.48 | < 0.001 |
PSI socre | - | 81.07 ± 7.74 | 130.43 ± 10.88 | < 0.001 |
NLR | - | 7.68 ± 1.37 | 8.05 ± 0.79 | 0.054 |